Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

REIMBURSEMENT UNRAVELLED: Bridging the gap with Germany’s NUB program

This article was originally published in Clinica

Executive Summary

Companies need no longer fear the reimbursement dead zone that new and costly technologies seem to find themselves in. The German NUB (Neue Untersuchungs- und Behandlungsmethoden) process is intended to allow for temporary additional reimbursement of these innovations in the German inpatient sector. In this third article in Clinica’s medtech reimbursement series, Medalliance’s Ben Modley explains the NUB concept and how it fits into the wider German DRG system

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101915

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel